Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform

BACKGROUND: Socioeconomic differences in receipt of adjuvant treatment contribute to persistent disparities in breast cancer (BCA) outcomes, including survival. Adjuvant endocrine therapy (AET) substantially reduces recurrence risk and is recommended by clinical guidelines for nearly all women with...

Descripción completa

Detalles Bibliográficos
Autores principales: Eom, Kirsten Y., van Londen, G. J., Li, Jie, Dahman, Bassam, Bradley, Cathy, Sabik, Lindsay M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088064/
https://www.ncbi.nlm.nih.gov/pubmed/33933027
http://dx.doi.org/10.1186/s12885-021-08149-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088064/
https://www.ncbi.nlm.nih.gov/pubmed/33933027
http://dx.doi.org/10.1186/s12885-021-08149-0

Ejemplares similares